03/31/24 |
NCI |
Notice of Special Interest (NOSI): Administrative Supplements for Assessing and Enhancing Survivorship Care |
Link |
NIH NOSI |
Application due: 06/05/24 |
01/17/24 |
NCI |
Notice of Special Interest: National Cancer Institute Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Prevention |
Link |
NIH NOSI |
Application due: 05/08/29 |
03/31/24 |
NCI |
Notice of Special Interest (NOSI): Developing and Testing Multi-level Physical Activity Interventions to Improve Health and Well-Being |
Link |
NIH NOSI |
Application due: 11/14/27 |
12/05/22 |
NIH |
Notice of Special Interest (NOSI): Advancing Development of Rapid Point-of-Care Hepatitis C Virus Diagnostics |
Link |
NIH NOSI |
Application due: 01/08/26 |
04/11/23 |
NIH |
Notice of Special Interest (NOSI): Research to Address Vaccine Uptake and Implementation among Populations Experiencing Health Disparities |
Link |
NIH NOSI |
Application due: 06/06/26 |
07/22/22 |
NIH |
Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Population, Clinical and Applied Prevention Mechanisms of Health Effects |
Link |
NIH NOSI |
Application due: 05/09/24 |
06/17/22 |
NIH |
Notice of Special Interest (NOSI): Developing Academic Research Enhancement Award (AREA) and Research Enhancement Award Program (REAP) for Institutions with an emphasis on Down syndrome research (R15 Clinical Trial Not Allowed) |
Link |
NIH NOSI |
Application due: 04/11/25 |
06/17/22 |
NIH |
Notice of Special Interest (NOSI): Availability of Administrative Supplements for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project |
Link |
NIH NOSI |
Application due: 06/02/25 |
04/10/23 |
NIH |
Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Population, Clinical and Applied Prevention Mechanisms of Health |
Link |
NIH NOSI |
Application due: 05/09/24 |
10/04/23 |
NCI |
Notice of Special Interest (NOSI): Mechanisms Driving Obesity and Prostate Cancer Risk |
Link |
NIH NOSI |
Application due: 09/08/24 |
12/20/23 |
NCI |
Notice of Special Interest (NOSI): Quantum Sensing Technologies in Biomedical Applications |
Link |
NIH NOSI |
Application due: 01/27/27 |
12/13/23 |
NCI |
Notice of Intent to Publish a Notice of Funding Opportunity for National Cancer Institute's Specialized Programs of Research Excellence (SPOREs) in Cancer Health Disparities and Minority Health (U54 Clinical Trial Optional) |
Link |
NIH NOSI |
Application due: 09/25/24 |
06/13/22 |
NIH |
Notice of Special Interest (NOSI): Climate Change and Health |
Link |
NIH NOSI |
Application due: 05/08/25 |
03/24/23 |
NCI |
Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Population, Clinical and Applied Prevention Mechanisms of Health Effects |
Link |
NIH NOSI |
Application due: 05/09/24 |
03/14/23 |
NCI |
Notice of Special Interest (NOSI): Disparities Affecting Healthcare Utilization and Health Outcomes Among Childhood Cancer Survivors |
Link |
NIH NOSI |
Application due: 10/09/24 |
03/11/24 |
NCI |
Notice of Special Interest (NOSI): Telehealth Research in Cancer Care |
Link |
NIH NOSI |
Application due: 03/17/26 |
05/27/22 |
NIH |
Notice of Special Interest (NOSI): Increasing Uptake of Evidence-Based Screening in Diverse Populations Across the Lifespan |
Link |
NIH NOSI |
Application due: 05/08/25 |
04/17/20 |
NIH |
Notice of Intent: New Funding Opportunity Announcement to Support Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19 |
Link |
NIH COVID-19 |
|
04/17/20 |
NIH |
NIH Funding Opportunities Specific to COVID-19 (various) |
Link |
NIH COVID-19 |
See list of notices for funding opps and due dates |
12/13/23 |
NCI |
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required) |
Link |
NIH |
Application due: 06/14/24 |
02/27/20 |
NIH |
Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required ) |
Link |
NIH |
|
08/01/18 |
NIH |
Secondary Analyses of Alcohol and Chronic Disease (R03) |
Link |
NIH |
Standard dates apply |
11/21/18 |
NIH |
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
08/13/20 |
NIH |
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
11/30/18 |
NIH |
Mentored Clinical Scientist Research Career Development Award (Parent K08 - Independent Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
09/11/20 |
NIH |
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
08/13/21 |
NIH |
Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
02/17/19 |
NIH |
End-of-Life and Palliative Care Health Literacy: Improving Outcomes in Serious, Advanced Illness (R21 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
03/08/23 |
NCI |
Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional) |
Link |
NIH |
Application due: 06/17/24 |
01/21/22 |
NIH |
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
05/06/19 |
NIH |
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21) |
Link |
NIH |
Standard due dates apply |
08/29/23 |
NCI |
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
08/02/19 |
NIH |
Ethical, Legal, and Social Implications (ELSI) of Genomics Exploratory/Developmental Research Grant Program (R21) |
Link |
NIH |
Standard due dates apply |
09/19/19 |
NIH |
Revision Applications for Mechanisms of Cancer Drug Resistance (U01 Clinical Trial Not Allowed) |
Link |
NIH |
|
03/11/24 |
NCI |
Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required) |
Link |
NIH |
Standard due dates apply |
08/01/18 |
NIH |
The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R21) |
Link |
NIH |
Standard dates apply |
11/21/18 |
NIH |
Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (R43/R44 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
11/30/18 |
NIH |
Mentored Clinical Scientist Research Career Development Award (Parent K08 - Independent Clinical Trial Required) |
Link |
NIH |
Standard due dates apply |
04/01/22 |
NCI |
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
02/07/20 |
NIH |
NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
08/13/21 |
NIH |
Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
02/17/19 |
NIH |
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) |
Link |
NIH |
Standard due dates apply |
01/21/22 |
NIH |
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required) |
Link |
NIH |
Standard due dates apply |
05/06/19 |
NIH |
Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts (U01) |
Link |
NIH |
Standard due dates apply |
07/17/19 |
NIH |
Maximizing the Scientific Value of Existing Biospecimen Collections (R21 Clinical Trial Not Allowed) |
Link |
NIH |
|
09/19/19 |
NIH |
Revision Applications for Mechanisms of Cancer Drug Resistance (R01 Clinical Trial Not Allowed) |
Link |
NIH |
|
03/11/24 |
NIH |
Model Continuums of Care Initiative (MCCI) to Advance Health Equity and End Health Disparities Among Women and Girls in Racial/Ethnic Minority and Other Underserved Communities (U34 Clinical Trials Required) |
Link |
NIH |
Application due: 06/18/24 |
02/14/20 |
NIH |
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33) |
Link |
NIH |
Standard due dates apply |
05/22/20 |
NIH |
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
11/22/19 |
NIH |
Early-life Factors and Cancer Development Later in Life (R01 - Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
11/30/18 |
NIH |
Mentored Patient-Oriented Research Career Development Award (Parent K23 - Independent Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
12/11/20 |
NCI |
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
02/14/20 |
NIH |
NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required) |
Link |
NIH |
Standard due dates apply |
08/06/21 |
NCI |
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
02/17/19 |
NIH |
PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
01/21/22 |
NIH |
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
08/11/23 |
NCI |
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
07/17/19 |
NIH |
Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed) |
Link |
NIH |
|
09/19/19 |
NIH |
Revision Applications for Mechanisms of Cancer Drug Resistance (P50 Clinical Trial Not Allowed) |
Link |
NIH |
|
03/11/24 |
NCI |
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required) |
Link |
NIH |
Application due: 06/14/24 |
02/14/20 |
NIH |
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) |
Link |
NIH |
Standard due dates apply |
05/15/20 |
NIH |
Advancing Research to Develop Improved Measures and Methods for Understanding Multimorbidity (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
11/15/18 |
NIH |
Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional) |
Link |
NIH |
Standard dates apply |
08/05/20 |
NIH |
Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
11/30/18 |
NIH |
Mentored Patient-Oriented Research Career Development Award (Parent K23 - Independent Clinical Trial Required) |
Link |
NIH |
Standard due dates apply |
04/01/22 |
NCI |
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
11/22/19 |
NIH |
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
07/22/22 |
NCI |
Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates |
02/17/19 |
NIH |
Fertility Status as a Marker for Overall Health (R01) |
Link |
NIH |
Standard due dates apply |
01/21/22 |
NIH |
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
08/11/23 |
NCI |
Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
03/10/22 |
NIH |
Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
09/19/19 |
NIH |
Revision Applications for Mechanisms of Cancer Drug Resistance (P01 Clinical Trial Not Allowed) |
Link |
NIH |
|
10/21/22 |
NIH |
National Cancer Institute Program Project Applications (P01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
05/08/20 |
NIH |
Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Not Allowed) |
Link |
NIH |
Standard dates apply |
05/15/20 |
NIH |
NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
11/22/19 |
NIH |
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)` |
Link |
NIH |
Standard dates apply |
08/05/20 |
NIH |
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed) |
Link |
NIH |
Standard due dates apply |
11/21/18 |
NIH |
Metabolic Reprogramming to Improve Immunotherapy (R01) |
Link |
NIH |
Standard due dates apply |
07/22/22 |
NCI |
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) |
Link |
NIH |
Application due: 06/11/24 |